CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- 4 Shares withheld for taxes GENERAL COUNSEL gave up 402 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations · Exit or restructuring costs
- 8-K Event Material agreement · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 8-K Event Exhibits
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- D Other Notice of Sales of Unregistered Securities
- S-3 Offering Registration Statement
- 8-K Event Material agreement · Results of operations · New debt or obligation · Exit or restructuring costs · Unregistered share sale · Regulation FD disclosure
- 424B5 Offering Prospectus
- 4 Grant or award Chief Operating Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 20,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 11 of 32 · 633 filings